Synopsys Shares (Diluted) increased by 2450.3% to 190.8M in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 22.1%, from 156.2M to 190.8M. Over 3 years (FY 2021 to FY 2025), Shares (Diluted) shows relatively stable performance with a 0.7% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.
An increase indicates potential dilution from employee compensation or convertible instruments, which can reduce earnings per share.
The weighted-average number of common shares outstanding plus the effect of all potentially dilutive securities, such as...
Standard metric for all public companies; essential for understanding the impact of equity-based compensation.
weighted_shares_diluted| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | 157.1M | 156.9M | 182K | 157.3M | 156.2M | 155.8M | 155.1M | 154.7M | 154.9M | 76K | 155.3M | 155.8M | 156.1M | 81K | 156.2M | 156.1M | 161.7M | 7.5M | 190.8M |
| QoQ Change | — | -0.1% | -99.9% | >999% | -0.7% | -0.2% | -0.5% | -0.2% | +0.1% | -100.0% | >999% | +0.3% | +0.2% | -99.9% | >999% | -0.1% | +3.6% | -95.4% | >999% |
| YoY Change | — | — | — | — | -0.6% | -0.7% | -1.4% | -0.9% | -0.6% | — | +0.2% | +0.7% | +0.8% | +6.6% | +0.6% | +0.2% | +3.6% | >999% | +22.1% |